The ExoVasc® PEARS provides an alternative to aortic root replacement. A personalised, custom-made external support is made to exactly match the patient’s aorta.
Learn more
Tal Golesworthy was a keynote speaker at the Bright Ideas in Health Awards ceremony, which was organised by NHS Innovations North and held at the
Tal Golesworthy was invited to give a presentation at the Medipex 2012 NHS Innovation Awards which was held on 11 October 2012 in Wakefield. Tal
The Second Thoracic Aortic Disease Summit was held on 1 and 2 August 2012 in Chicago, Illinois, just before the National Marfan Foundation Annual Meeting
The European Society of Cardiology’s annual meeting was held in Munich on 25 – 29 August. The meeting is the biggest cardiovascular forum and attracts
The Journal of Interactive and Cardio Thoracic Surgery published an article on PEARS treatment, highlighting the free egress of the coronary arteries through the Exovasc.
On 13 April 2012, Tal Golesworthy presented at the annual Sigma Symposium at the Radboud University of Nijmegen. Tal’s paper was ‘The Exostent: simple is
On 20 October 2011, Tal Golesworthy gave a paper at TEDxKraków called Barriers and benefits in multidisciplinary innovation. His paper is now available online and
The 2012 Marfan Association UK Annual Information Day was held on 17 March at St George’s Hospital University of London in Tooting. A series of
Just published in BMJ Open is “A method for early evaluation of a recently introduced technology by deriving a comparative group from existing clinical data:
Tal Golesworthy and Professor John Pepper gave a talk at the NIHR Cardiovascular Biomedical Research Unit’s Cafe scientifique on Wednesday 8 February.
We develop medical devices that manage aortic dilation and minimise the risk of aortic dissection.